Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

Eli Lilly data shows patients maintain weight loss with Foundayo or lower-dose Zepbound after switching from injectable therapies.

Eli Lilly Announces Detailed Results From Two Late-Phase Trials Showing That People With Obesity Maintained Their Weight Loss Long Term With Either Foundayo Or Lower-Dose Zepbound After Switc

Eli Lilly and Company (NYSE:LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after

Watching Eli Lilly; Hearing Zacks Tech Innovator Newsletter Mentions Stock As A Buy

Roche, Eli Lilly Alzheimer's Blood Test Cleared In Europe For Earlier Detection

Roche secured European CE Mark approval for its Elecsys pTau217 Alzheimer's blood test developed with Eli Lilly.

Jim Cramer Won't 'Dump' This Medical Device Maker, Passes On Ford

"I don't understand how this thing could have fallen so fast," the Mad Money host said of the medical device maker.

Roche And Lilly's Elecsys pTau217 Wins CE Mark As First Single-Assay Blood Test Offering Spinal Fluid-Comparable Accuracy To Rule In And Rule Out Alzheimer's Amyloid Pathology

Elecsys pTau217 is the first blood test for Alzheimer's disease pathology with a single‑assay design, intended to rule in and rule out amyloid pathology across primary and secondary care, offering faster diagnosis for

Trump Admin Proposes New IVF Benefit To Expand Fertility CoverageThrough Employers

Trump administration proposes new IVF benefits rule aimed at expanding employer fertility coverage and lowering treatment costs.

'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive

Health officials explored restricting specific antidepressants among SSRI drugs-sources

Omada Health To Serve As Program Administrator In Eli Lilly's Employer Connect Program

Omada Health (NASDAQ:OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada will offer its GLP‑1 Care Track, including clinical evaluation,

Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites

Eli Lilly plans to invest $4.5 billion in Indiana, expanding its U.S. manufacturing footprint and supporting new weight-loss treatments.